Evidence map›Paper›PMID 37264302›Full record

ArticleBMC gastroenterology2023

Long- and short-term outcomes of balloon dilation for benign choledochojejunal anastomotic stricture using balloon endoscopy-assisted ERCP: a multi-center retrospective cohort study.

Yuhei Iwasa, Takuji Iwashita, Keisuke Iwata, Shinya Uemura, Mitsuru Okuno, Ryuichi Tezuka, Akihiko Senju, Tsuyoshi Mukai, Masahito Shimizu

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in BMC gastroenterology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Yuhei IwasaDepartment of Gastroenterology, Gifu Municipal Hospital, 7-1 Kashima-Cho, Gifu City, Gifu 500-8513, Japan.
Takuji IwashitaFirst Department of Internal Medicine, Gifu University Hospital, 1-1 Yanagido, Gifu City, Gifu 501-1194, Japan. takuji@w7.dion.ne.jp.
Keisuke IwataDepartment of Gastroenterology, Gifu Municipal Hospital, 7-1 Kashima-Cho, Gifu City, Gifu 500-8513, Japan.
Shinya UemuraFirst Department of Internal Medicine, Gifu University Hospital, 1-1 Yanagido, Gifu City, Gifu 501-1194, Japan.
Mitsuru OkunoDepartment of Gastroenterology, Gifu Municipal Hospital, 7-1 Kashima-Cho, Gifu City, Gifu 500-8513, Japan.
Ryuichi TezukaFirst Department of Internal Medicine, Gifu University Hospital, 1-1 Yanagido, Gifu City, Gifu 501-1194, Japan.
Akihiko SenjuFirst Department of Internal Medicine, Gifu University Hospital, 1-1 Yanagido, Gifu City, Gifu 501-1194, Japan.
Tsuyoshi MukaiDepartment of Gastroenterological Endoscopy, Kanazawa Medical University, Ishikawa, Japan.
Masahito ShimizuFirst Department of Internal Medicine, Gifu University Hospital, 1-1 Yanagido, Gifu City, Gifu 501-1194, Japan.
Gifu University Hospital · JPGifu Municipal Hospital · JPKanazawa Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBenign choledochojejunal anastomotic stricture (CJS) is a common complication of pancreaticoduodenectomy and choledochojejunostomy. CJS is generally treated with balloon dilation, using balloon endoscopy-assisted endoscopic retrograde cholangiopancreatography (BE-ERCP); however, its long- and short-term outcomes have not been fully evaluated. Therefore, we evaluated the treatment outcomes of balloon dilation with BE-ERCP for CJS.

methodsWe retrospectively analyzed 40 patients who had undergone balloon dilation with BE-ERCP for CJS between January 2009 and December 2022. The primary outcomes were technical and clinical success, and adverse event rates of balloon dilation using BE-ERCP for CJS. The secondary outcomes were long-term treatment outcomes for CJS recurrence, and evaluation of risk factors for recurrence.

resultTechnical and clinical success rates were 93% (37/40) and 100% (37/37), respectively. CJS recurrence occurred in 32% (20/37). No procedure-related adverse events were observed. The significant risk factors of CJS after balloon dilation were its early occurrence after surgery (unit hazard ratio [HR] for month, 0.87; 95% confidence interval [CI], 0.76-0.99; p-value = 0.04) and residual waist during balloon dilation (HR, 5.46; 95% CI, 1.18-25.1; p-value = 0.03). Receiver operating characteristic curve analysis of time from surgery to balloon dilation revealed an area under the curve of 0.80 (95% CI, 0.65-0.94) and the cut-off value was 13.2 months.

conclusionTreatment of CJS with balloon dilation was effective, although CJS recurrence occurred in one-third of the patients. The risk factors for recurrence were early occurrence of CJS after surgery and remaining waist circumference during balloon dilation.

Indexed as

Cholangiopancreatography, Endoscopic RetrogradeNeoplasm Recurrence, LocalConstriction, PathologicDilatationHumansRetrospective StudiesTreatment OutcomeBalloon dilationBalloon endoscopy-assisted ERCPCholedochojejunal anastomotic stricturePancreaticoduodenectomy

Identifiers

PMID37264302
PMCPMC10236745
OpenAlexW4379056624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.